Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Successful Treatment of Idiopathic Multicentric Castleman Disease With Rash as the Initial Symptom Using a Rituximab-Based Regimen.

Autor: Zhu L; Department of Hematology, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou 310003, Zhejiang, China.; Zhejiang Provincial Clinical Research Center for Hematological Disorders, Hangzhou 310003, Zhejiang, China.; Zhejiang Provincial Key Laboratory of Hematopoietic Malignancy, Zhejiang University, Hangzhou 310003, Zhejiang, China.; These authors contributed equally to this article., Liu Y; Department of Hematology, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou 310003, Zhejiang, China.; Zhejiang Provincial Clinical Research Center for Hematological Disorders, Hangzhou 310003, Zhejiang, China.; These authors contributed equally to this article., Yu F; Department of Pathology, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou 310003, Zhejiang, China.; These authors contributed equally to this article., Yin XJ; Department of Hematology, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou 310003, Zhejiang, China.; Zhejiang Provincial Clinical Research Center for Hematological Disorders, Hangzhou 310003, Zhejiang, China.; Zhejiang Provincial Key Laboratory of Hematopoietic Malignancy, Zhejiang University, Hangzhou 310003, Zhejiang, China., Yao QM; Department of Hematology, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou 310003, Zhejiang, China.; Zhejiang Provincial Clinical Research Center for Hematological Disorders, Hangzhou 310003, Zhejiang, China.; Zhejiang Provincial Key Laboratory of Hematopoietic Malignancy, Zhejiang University, Hangzhou 310003, Zhejiang, China., Meng HT; Department of Hematology, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou 310003, Zhejiang, China.; Zhejiang Provincial Clinical Research Center for Hematological Disorders, Hangzhou 310003, Zhejiang, China.; Zhejiang Provincial Key Laboratory of Hematopoietic Malignancy, Zhejiang University, Hangzhou 310003, Zhejiang, China., You LS; Department of Hematology, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou 310003, Zhejiang, China.; Zhejiang Provincial Clinical Research Center for Hematological Disorders, Hangzhou 310003, Zhejiang, China.; Zhejiang Provincial Key Laboratory of Hematopoietic Malignancy, Zhejiang University, Hangzhou 310003, Zhejiang, China., Tong HY; Department of Hematology, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou 310003, Zhejiang, China.; Zhejiang Provincial Clinical Research Center for Hematological Disorders, Hangzhou 310003, Zhejiang, China.; Zhejiang Provincial Key Laboratory of Hematopoietic Malignancy, Zhejiang University, Hangzhou 310003, Zhejiang, China.

Publikováno v: Journal of hematology [J Hematol] 2024 Oct; Vol. 13 (5), pp. 245-249. Date of Electronic Publication: 2024 Oct 21.

CAG regimen for refractory or relapsed adult T-cell acute lymphoblastic leukemia: A retrospective, multicenter, cohort study.

Autor: Qian JJ; Department of Hematology, the First Affiliated Hospital, College of Medicine, Zhejiang University, Zhejiang, China.; Institute of Hematology, Zhejiang University, Zhejiang, China.; Zhejiang Province Key Laboratory of Hematology Oncology Diagnosis and Treatment, Hangzhou, China., Hu X; Department of Hematology, Institute of Hematology, Changhai Hospital, Shanghai, China., Wang Y; Department of Hematology, Shanghai Jiaotong University School of Medicine Affiliated Ruijin Hospital North, Shanghai, China., Zhang Y; Department of Hematology, the First Affiliated Hospital, College of Medicine, Zhejiang University, Zhejiang, China.; Institute of Hematology, Zhejiang University, Zhejiang, China.; Zhejiang Province Key Laboratory of Hematology Oncology Diagnosis and Treatment, Hangzhou, China., Du J; Department of Hematology, Shanghai Changzheng Hospital, The Second Military Medical University, Shanghai, China., Yang M; Department of Hematology, the First Affiliated Hospital, College of Medicine, Zhejiang University, Zhejiang, China.; Institute of Hematology, Zhejiang University, Zhejiang, China.; Zhejiang Province Key Laboratory of Hematology Oncology Diagnosis and Treatment, Hangzhou, China., Tong H; Department of Hematology, the First Affiliated Hospital, College of Medicine, Zhejiang University, Zhejiang, China.; Institute of Hematology, Zhejiang University, Zhejiang, China.; Zhejiang Province Key Laboratory of Hematology Oncology Diagnosis and Treatment, Hangzhou, China., Qian WB; Department of Hematology, the First Affiliated Hospital, College of Medicine, Zhejiang University, Zhejiang, China.; Institute of Hematology, Zhejiang University, Zhejiang, China.; Zhejiang Province Key Laboratory of Hematology Oncology Diagnosis and Treatment, Hangzhou, China., Wei J; Department of Hematology, the First Affiliated Hospital, College of Medicine, Zhejiang University, Zhejiang, China.; Institute of Hematology, Zhejiang University, Zhejiang, China.; Zhejiang Province Key Laboratory of Hematology Oncology Diagnosis and Treatment, Hangzhou, China., Yu W; Department of Hematology, the First Affiliated Hospital, College of Medicine, Zhejiang University, Zhejiang, China.; Institute of Hematology, Zhejiang University, Zhejiang, China.; Zhejiang Province Key Laboratory of Hematology Oncology Diagnosis and Treatment, Hangzhou, China., Lou YJ; Department of Hematology, the First Affiliated Hospital, College of Medicine, Zhejiang University, Zhejiang, China.; Institute of Hematology, Zhejiang University, Zhejiang, China.; Zhejiang Province Key Laboratory of Hematology Oncology Diagnosis and Treatment, Hangzhou, China., Mao L; Department of Hematology, the First Affiliated Hospital, College of Medicine, Zhejiang University, Zhejiang, China.; Institute of Hematology, Zhejiang University, Zhejiang, China.; Zhejiang Province Key Laboratory of Hematology Oncology Diagnosis and Treatment, Hangzhou, China., Tao Meng H; Department of Hematology, the First Affiliated Hospital, College of Medicine, Zhejiang University, Zhejiang, China.; Institute of Hematology, Zhejiang University, Zhejiang, China.; Zhejiang Province Key Laboratory of Hematology Oncology Diagnosis and Treatment, Hangzhou, China., You LS; Department of Hematology, the First Affiliated Hospital, College of Medicine, Zhejiang University, Zhejiang, China.; Institute of Hematology, Zhejiang University, Zhejiang, China.; Zhejiang Province Key Laboratory of Hematology Oncology Diagnosis and Treatment, Hangzhou, China., Wang L; Department of Hematology, Institute of Hematology, Changhai Hospital, Shanghai, China., Li X; Department of Hematology, the First Affiliated Hospital, College of Medicine, Zhejiang University, Zhejiang, China.; Institute of Hematology, Zhejiang University, Zhejiang, China.; Zhejiang Province Key Laboratory of Hematology Oncology Diagnosis and Treatment, Hangzhou, China., Huang X; Department of Hematology, the First Affiliated Hospital, College of Medicine, Zhejiang University, Zhejiang, China.; Institute of Hematology, Zhejiang University, Zhejiang, China.; Zhejiang Province Key Laboratory of Hematology Oncology Diagnosis and Treatment, Hangzhou, China., Cao LH; Department of Hematology, Shulan (Hangzhou) Hospital, Hangzhou, China., Zhao JZ; Department of hematology, Shaoxing Central Hospital, Shaoxing, China., Yan Yan X; Department of Biostatistics, Peking University Clinical Research Institute, Beijing, China., Chen YB; Department of Hematology, Shanghai Jiaotong University School of Medicine Affiliated Ruijin Hospital North, Shanghai, China., Chen Y; Department of Hematology, Shanghai Jiaotong University School of Medicine Affiliated Ruijin Hospital North, Shanghai, China., Zhang SJ; Department of Hematology, Shanghai Jiaotong University School of Medicine Affiliated Ruijin Hospital North, Shanghai, China., Jin J; Department of Hematology, the First Affiliated Hospital, College of Medicine, Zhejiang University, Zhejiang, China.; Institute of Hematology, Zhejiang University, Zhejiang, China.; Zhejiang Province Key Laboratory of Hematology Oncology Diagnosis and Treatment, Hangzhou, China., Hu J; Shanghai Institute of Hematology, Department of Hematology, Blood and Marrow Transplantation Center, Collaborative Innovation Center of Hematology, RuiJin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China., Zhu HH; Department of Hematology, the First Affiliated Hospital, College of Medicine, Zhejiang University, Zhejiang, China.; Institute of Hematology, Zhejiang University, Zhejiang, China.; Zhejiang Province Key Laboratory of Hematology Oncology Diagnosis and Treatment, Hangzhou, China.

Publikováno v: Cancer medicine [Cancer Med] 2020 Aug; Vol. 9 (15), pp. 5327-5334. Date of Electronic Publication: 2020 Jun 03.